Novo Nordisk A/S (NVO)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $183.52B
Last updated: Nov 17, 2026 at 11:06 AM ET
Novo Nordisk A/S (NVO) Competitors
The companies most similar to Novo Nordisk A/S are Sanofi ADR (SNY), Novartis AG ADR (NVS) and AstraZeneca (AZN). By market cap, Novo Nordisk A/S ranks 8th of the 13 companies on this page; Johnson & Johnson (JNJ) is the largest at $687.89B. The median P/E of the 10 companies with a P/E is 20.7x.
Peer Comparison
NVO's ROIC of 34.1% is above the peer median of 12.8%, and its revenue growth of 5.6% is below the median of 6.8%. Its dividend yield is above the peer median of 2.35%.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| Novartis AG ADR (NVS) | $303.12B | 18.7x | 5.4x | 17.5% | 13.5% | 4.7% | 2.98% |
| AstraZeneca PLC (AZN) | $286.07B | 22.5x | 4.6x | 17.7% | 14.9% | 6.7% | 1.16% |
| GSK plc (GSK) | $101.13B | 10.5x | 2.3x | 13.0% | N/A | 4.0% | 3.58% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| Gilead Sciences Inc (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| Pfizer Inc (PFE) | $164.67B | 9.5x | 2.6x | 6.3% | 2.7% | -0.4% | 5.96% |
| Merck & Company Inc (MRK) | $364.26B | 46.3x | 5.3x | 3.6% | 3.1% | 4.7% | 2.35% |
| AbbVie Inc (ABBV) | $521.50B | 23.0x | 7.9x | 15.7% | 16.4% | 10.3% | 2.35% |
| Biogen Inc (BIIB) | $37.46B | 21.4x | 3.6x | 3.4% | 1.3% | 10.6% | 0.00% |
| Johnson & Johnson (JNJ) | $687.89B | 26.6x | 6.9x | 16.2% | 12.8% | 5.9% | 1.90% |
| Peer median | $230.18B | 20.7x | 5.0x | 14.3% | 12.8% | 6.8% | 2.35% |
Similar Companies
These are the 12 companies most similar to Novo Nordisk A/S, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.
| Company | About | Peers |
|---|---|---|
| Sanofi ADR (SNY) | Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe... | SNY competitors |
| Novartis AG ADR (NVS) | Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland. | NVS competitors |
| AstraZeneca PLC (AZN) | AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory... | AZN competitors |
| GSK plc (GSK) | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines... | GSK competitors |
| Bristol-Myers Squibb Company (BMY) | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| Gilead Sciences Inc (GILD) | Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California... | GILD competitors |
| Amgen Inc (AMGN) | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
| Pfizer Inc (PFE) | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. | PFE competitors |
| Merck & Company Inc (MRK) | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. | MRK competitors |
| AbbVie Inc (ABBV) | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. | ABBV competitors |
| Biogen Inc (BIIB) | Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development... | BIIB competitors |
| Johnson & Johnson (JNJ) | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. | JNJ competitors |
Frequently Asked Questions About NVO
Who are Novo Nordisk A/S' main competitors?
The companies most similar to Novo Nordisk A/S include Sanofi ADR (SNY), Novartis AG ADR (NVS), AstraZeneca (AZN), GSK (GSK) and Bristol-Myers Squibb Company (BMY), listed from the closest match.
Who is Novo Nordisk A/S' biggest competitor?
Johnson & Johnson (JNJ) is the largest of the similar companies at $687.89B; Sanofi ADR (SNY) is the closest match by business profile, size, sector and industry.
How does NVO stock compare with its competitors?
NVO's P/S is 3.6x against a peer median of 5.0x; its net margin is 33.9% against a peer median of 14.3%.
Which of Novo Nordisk A/S' competitors pays a higher dividend?
Novo Nordisk A/S has a forward dividend yield of 4.32%. Pfizer (PFE) and Sanofi ADR (SNY) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.
Is Novo Nordisk A/S bigger than its competitors?
No. Novo Nordisk A/S is 8th by market cap among the 13 companies on this page; the largest is Johnson & Johnson (JNJ) at $687.89B.
NVO pages: Overview, Dividends, Financials, Valuation, Competitors